ARCHIVES

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Concept For 14-19 New Grants, Four New Contracts

November 4, 1988

NCI Drops Protocol Review Requirement To Encourage firs To List Trials On PDQ

October 24, 1997

DCCP Board Defers Two Concept Requests, Approves Sole Sources

October 22, 1982

IOM Omics Committee Offers Blueprint to Prevent Other Duke-Style Disasters

March 23, 2012

In Brief: Philadelphia Chromosome Discoverer Hungerford Dead; Oregon Recruits Scientists

November 12, 1993

Loeb Named ACS President, Eyre President Elect

November 14, 1986